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have preserved affinity to the hIFNc receptor, but to be deprived
in their capability to trigger the intracellular signal transduction.
To this end a library of mutants was created and two poten-
tial hIFNc antagonists were selected for further investigations: a
single point mutant K88Q (Q substitution for K in position 88)
and a double mutant with additional substitution in the N-termi-
nus. Both mutants and the wild type hIFNc were expressed in
E. coli employing the established by us methodology for large
scale production of aggregation-prone proteins in soluble native
form. The purified mutants were screened for interferon activity
(antiproliferative assay), binding affinity (isothermal titration
calorimetry) and ability to compete with the wild type for the
hIFNc receptor (competition assay on WISH cells).
The selected mutants demonstrated 100 (single mutant) and
1000 (double mutant) times lower antiproliferative activity than
the wild type. Measuring the binding thermodynamic parameters,
we proved that the receptor binding affinity of both mutants was
preserved, which is an indication for their potential to compete
with the wild type hIFNc for its receptor. Finally, the biological
assay performed on WISH cells showed a distinct dose-dependent
competition between the wild type hIFNc and the mutants.
Based on the results presented in this study we conclude that
the two hIFNc mutants are potential candidates for autoimmune
therapy based on selective suppression of the endogenous hIFNc
activity.
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MANF may attenuate hypoxia/reperfusion-
induced renal cell injury
F. Aydin Kose, P. Ballar Kirmizibayrak, A. Pabuccuoglu
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Biochemistry, Izmir, Turkey
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is
an ER (endoplasmic reticulum) stress-inducible protein and
widely expressed in mammalian tissues. It has been identified as
a secretory protein that protects cells against ER stress-induced
damage. ER-stress is one of the main mechanisms that play a
role in ischemia/reperfusion (I/R)- induced renal injury. Recent
studies demonstrated that MANF can protect cardiac myocytes
and cortical neurons against I/R-induced injury. Moreover, it has
been suggested that it has a restorative effect in ischemic injury.
Nevertheless, the function of MANF in I/R-induced renal injury
is still not known.
In the present study, we investigated the function of MANF
by manipulation its expression level in ischemic acute renal fail-
ure model established in proximal tubular kidney cells (HK-2
cells).
For this purpose, the cells were transfected with either MANF
siRNA or MANF encoding plasmids for silencing or over-expres-
sion of MANF, respectively. Then, the cells were exposed to
hypoxia-reperfusion (H/R) induction for indicated times. Evalua-
tions of cell viability were determined with WST-1 reagent. The
changes in protein levels of H/R-induced stress markers were
analyzed byimmunoblotting.
The results showed that the overexpression of MANF has
provided a significant resistance to H/R-induced cell death,
whereas silencing of MANF has rendered the cells more suscepti-
ble to death. It was also determined that the pretreatment of cells
with MANF conditioned medium caused a decrease in cell death.
Additionally, oxidative/nitrosative stress (OS/NS) and ER
stress levels were decreased with over-expression of MANF and
increased by silencing of MANF in HK-2 cells.
Taken together, our study suggests that MANF may have a
protective role against H/R-induced renal cell injury, possibly
through the reducing effects on OS/NS and ER stress.
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His-flag tag as a fusion partner in insect
expression system – gain or loss?
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Human interferon gamma (hIFNc) is a glycoprotein playing
major role in the regulation of innate and adaptive immunity.
Glycosylation is not essential for hIFNc activity but is important
for its stability, half-life and protease resistance in blood. The
commonly used hIFNc in therapy and research is produced in
E. coli and therefore is not glycosylated. Bearing in mind the
above mentioned shortcomings of the non-glycosylated hIFNc
we expressed it in mammalian cells and transgenic mice, however
very low yields were achieved. To obtain glycosylated hIFNc,
here we employed a secretory expression of N-terminal HIS-
FLAG fusion protein in baculovirus-infected insect High Five
cells. This small hydrophilic tag is designed to not affect the
proper folding of the target protein and to facilitate the detection
and purification procedures. In parallel the same fusion was
expressed in E. coli cells. The fusion proteins were purified to
high degree of purity by affinity and size-exclusion chromatogra-
phy. Bioassay carried out on WISH cells showed that the
antiproliferative activity of both fusion proteins was 500 times
lower than that of the native hIFNc. This result shows that, in
contrast to the generally hold view, the N-terminal HIS-FLAG
tag interferes with the biological activity of hIFNc despite of the
protein glycosylation. In order to restore the biological activity
we attempted to remove the HIS-FLAG tag enzymatically. Sur-
prisingly, we found that the fusion protein obtained from insect
cells was resistant to enterokinase, independently of the enzyme
source and experimental conditions, whereas the protein isolated
from E. coli was susceptible and the tag-free protein showed fully
restored biological activity. We are prone to explain the enteroki-
nase resistance of the fusion protein from insect cells with either
the specific conformation of the glycosylated protein or with the
interaction of the carbohydrate residues with the enzymatic activ-
ity of the enterokinase.
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Development of fluorescence assay for high-
throughput screening system based on flow
cytometry for directed evolution of cellobiose
dehydrogenase
M. Blazic
IChTM, Belgrade, Serbia
Cellobiose dehydrogenase (CDH) is an enzyme produced by
Phanerochaete Chrysosporium and it has been already successfully
cloned in other organisms. One of the most important roles of
CDH is removing products of cellulose degradation. CDH is very
important for biofuel and biosensor industry. For improvements
of enzyme properties we have used directed evolution. The most
important step is to develop screening system that reflects proper-
ties of interest. Screening in microtiter plates (MTP) is expensive,
time-consuming and has low throughput with a small number of
variants detected (103–104 in months).
The aim of this work was the development of screening system
for mutant libraries of CDH expressed on surface of yeast cells
based on fluorescent enzymatic assay and flow cytometry. The
screening method should be capable of screening cellobiose dehy-
drogenase variants mutated for higher activity and higher ther-
mostability by error prone PCR. The fluorescent assay was
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evaluated in MTP and compared with DCIP assay. For further
work the fluorescent assay will be tested using yeast cells with
expressed active CDH on yeast surface using fluorescent acti-
vated cell sorter detection system.
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Purification, characterization and gene cloning
of beta-galactosidase from Arthrobacter
sulfonivorans
A. Kastsianevich
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Beta-galactosidase (EC 3.2.1.23) also known as lactase is the
enzyme that typically catalyzes hydrolysis of beta-1,4-D-galactosi-
dic linkages in beta-D-galactosides, including disaccharide lac-
tose, with glucose and galactose as end reaction products. This
enzyme is able to catalyze synthesis of oligosaccharides, in partic-
ular galactooligosaccharides via galactosyl transfer reaction.
Arthrobacter sulfonivorans beta-galactosidase of unique for
prokaryotes extracellular localization may find application in
food industry for manufacturing lactose-free dairy products and
in pharmacology as bioactive principle of medicines prescribed
for patients suffering from lactase deficiency.
The study was aimed at cloning of the gene encoding A. sul-
fonivorans beta-galactosidase, purification and characterization of
the enzyme.
A novel extracellular beta-galactosidase from A. sulfonivorans
was recovered with an overall 207-fold purification, a 7.7% yield
and specific activity 16 300 Umg1 protein. The subunit molecu-
lar mass of the enzyme determined by SDS-PAGE analysis equal-
led 125 kDa. It was found that the enzyme displays pI 5.35,
prefers ortho-nitrophenyl-beta-galactoside as substrate (Km
27 mM) and shows maximum activity at 40°C and at pH 7.5–9.5.
The beta-galactosidase gene was isolated from the genomic
DNA library of A. sulfonivorans, sequenced, cloned and depos-
ited in the GenBank database under accession number
KM277894.1. It was established that the gene carries an open
reading frame consisting of 3132 bp (1043 amino acids) and
encodes beta-galactosidase referred to Glycosyl Hydrolase Family
2 (CAZy database).
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Different splice-forms of TDRD7 protein
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with S6K1/2
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Ribosomal S6 kinases (S6K) are important players in cellular
PI3K/mTOR signalling network, deregulation of which has been
associated with methabolic disorders, inflammation and cancer.
Previously we had identified a novel binding partner of S6K1 –
TDRD7 (Trap). TDRD7 is a scaffold protein detected in com-
plexes involved in the regulation of cytoskeleton dynamics,
mRNA transport, protein translation, non-coding piRNAs pro-
cessing, transposons silensing. It was reported recently that muta-
tions in human TDRD7 result in cataract and glaucoma
formation, defined by elevated intraocular pressure (IOP) and
optic nerve damage.
The aim of our study was to confirm S6K-TDRD7 interaplay
and study its role in cells.
Bioinformatical analysis of TDRD7 sequence revealed the
presence of potential phosphorylation sites of S6K2. Using
in vitro kinase assay, we have demonstrated that recombinant
S6K2 phosphorylate 3 from 5 fragments of TDRD7. Formation
of S6K2-TDRD7 complexes in vivo was further confirmed by co-
immunoprecipitation using anti-S6K2 and anti-TDRD7 antibod-
ies generated previously in rat brain lysates. This interaction was
further confirmed by confocal microscopy, Oleksandr had shown
that TDRD7 co-localize with S6K2 in HEPG2 cells, predomi-
nantly in perinuclear region, enreached for one of the TDRD7
isoforms identified previously.
Moreover, we have detected that C-terminal synthetic peptides
of S6K2 with methylated Arg interfere with TDRD7 from
HEPG2 lysates. The physiological characteristics of S6K2-
TDRD7 interaction and the role of this complex formation in
neuropathology’s development need further investigation.
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Very stable high molecular mass multi-protein
complex from human placenta
E. E. Burkova, G. A. Nevinsky
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Novosibirsk, Russia
Many biological function of placenta are performed not just a set
of individual proteins, but also different oligomeric structures and
complexes. Herewith, activities of complexes may considerably
differ from activities of individual proteins. Therefore, identifica-
tion and characterization of placental multi-protein complexes is
an important step to understanding the placenta function.
The aim of the present work was to investigate a composition
and biological functions of the very stable high molecular mass
multi-protein complexes (SPC) from placenta of healthy mother.
We isolated SPCs (~1000 kDa) from the soluble fraction of
three human placentas. Light scattering measurements and gel fil-
tration showed that the SPC is stable in presence salts, acetoni-
trile and Triton X-100 in high concentrations, but efficiently
dissociates in the presence of 8 M urea and 50 mM EDTA. Such
a stable complex is unlikely to be a random associate of different
proteins. It was shown the SPC includes a number of proteins
with molecular weights of 2 to 180 kDa. Several protein compo-
nents of the SPC were identified, including serum albumin, trans-
ferrin, IgGs, annexin A5 and other proteins. Serum albumin,
transferrin and protein with molecular weight 14,1 kDa are the
main proteins of the complex. It was shown high the SPCs from
three placentas possesses DNSase and catalase activities. An
addition, investigation of cytotoxic effect on human cancerous
cell lines has shown that the SPCs reveal high cytotoxicity.
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Antibody-cytochrome b5 fusion protein,
characterization and applications for antibody
development process
D. Dormeshkin
Institute of Bioorganic Chemistry NASB, Minsk, Belarus
Antibodies have recently become an essential tool being a part of
immunodiagnostics, therapeutics and as a valuable instrument in
life science research. An enormous number of options utilizing a
various tags were used to create a universal antigen-binding
domain, which can be easily detectable, highly soluble and might
be produced in high yields with low costs, but no multipurpose
solution exists yet.
We addressed the question whether a single tag could be
found for enhancing solubility of recombinant Fab antibody
fragment and providing its detection and accurate quantification
by rather simple method.
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